Aigen Investment Management LP decreased its holdings in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 34.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 19,477 shares of the company's stock after selling 10,400 shares during the period. Aigen Investment Management LP's holdings in Doximity were worth $849,000 as of its most recent SEC filing.
Other institutional investors have also recently added to or reduced their stakes in the company. GAMMA Investing LLC grew its position in shares of Doximity by 40.1% during the third quarter. GAMMA Investing LLC now owns 1,439 shares of the company's stock worth $63,000 after acquiring an additional 412 shares during the last quarter. Van ECK Associates Corp grew its position in Doximity by 19.7% in the 2nd quarter. Van ECK Associates Corp now owns 2,590 shares of the company's stock valued at $72,000 after buying an additional 427 shares in the last quarter. Cornercap Investment Counsel Inc. grew its position in Doximity by 3.2% in the 2nd quarter. Cornercap Investment Counsel Inc. now owns 17,143 shares of the company's stock valued at $479,000 after buying an additional 537 shares in the last quarter. Farther Finance Advisors LLC grew its position in Doximity by 324.2% in the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company's stock valued at $34,000 after buying an additional 603 shares in the last quarter. Finally, Arizona State Retirement System lifted its holdings in Doximity by 2.4% in the 2nd quarter. Arizona State Retirement System now owns 30,779 shares of the company's stock valued at $861,000 after acquiring an additional 725 shares during the last quarter. Institutional investors own 87.19% of the company's stock.
Wall Street Analyst Weigh In
A number of equities research analysts have weighed in on the stock. Evercore ISI upped their price target on shares of Doximity from $34.00 to $45.00 and gave the company an "in-line" rating in a report on Tuesday, October 8th. KeyCorp raised shares of Doximity from a "sector weight" rating to an "overweight" rating and set a $70.00 price target for the company in a report on Friday, November 8th. Canaccord Genuity Group reaffirmed a "hold" rating and set a $60.00 price objective (up from $40.00) on shares of Doximity in a research note on Wednesday. Bank of America upped their price objective on shares of Doximity from $32.00 to $45.00 and gave the company a "neutral" rating in a research note on Monday, October 7th. Finally, Robert W. Baird upped their price objective on shares of Doximity from $41.00 to $45.00 and gave the company an "outperform" rating in a research note on Tuesday, September 17th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, Doximity currently has an average rating of "Hold" and a consensus price target of $48.14.
Read Our Latest Stock Analysis on DOCS
Doximity Stock Performance
Shares of NASDAQ DOCS traded down $5.17 during mid-day trading on Wednesday, reaching $52.88. The company had a trading volume of 4,317,333 shares, compared to its average volume of 1,731,640. The stock has a fifty day moving average of $42.48 and a two-hundred day moving average of $33.68. The company has a market capitalization of $9.82 billion, a price-to-earnings ratio of 61.68, a PEG ratio of 5.08 and a beta of 1.30. Doximity, Inc. has a 12-month low of $22.96 and a 12-month high of $61.75.
Doximity Company Profile
(
Free Report)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Featured Stories
Before you consider Doximity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.
While Doximity currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.